In 2025, the initial public offering (IPO) market continued to rebound from the 2022 and 2023 slump. For the second year in a row, markets saw more IPOs, more special purpose acquisition companies ...

Veradermics, a small biotechnology company looking to develop drugs for hair loss, enjoyed a stunning debut on Wall Street Wednesday. And that’s no bald-faced lie. (Sorry. Not sorry.) Shares of ...

Eikon Therapeutics is heading to the Nasdaq this morning with an upsized $381 million IPO in a further sign of the renewed appeal of the public markets. The oncology biotech will offer 21.2 million ...

York Space Systems began public trading Jan. 29, 2026, on the New York Stock Exchange under the ticker YSS. Credit: York Space Systems WASHINGTON — An investor in two space companies that went public ...

Feb 9 (Reuters) - U.S. equity markets are set for a sharp rebound in IPOs in 2026, Goldman Sachs analysts said, forecasting proceeds quadrupling to a record $160 billion as marquee names such as ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eikon Therapeutics increased the ...

Tyler Letarte, a principal at private equity firm AE Industrial Partners, said the sheer scale of a SpaceX IPO would force investors worldwide to take a closer look at the space sector. Credit: ...

A roughly $1 billion initial public offering by Malaysia’s Sunway Healthcare is drawing interest from high-profile investors like AIA, J.P. Morgan Asset Management and International Finance Corp. The ...

Kraken sacked its chief financial officer, Stephanie Lemmerman, just as the crypto exchange prepares to publicly list in the U.S. in the early part of this year, according to two people familiar with ...

Retail giant Walmart went public in 1969, and seemed unstoppable for the next 30 years. It was caught flat-footed by the e-commerce revolution, but has made serious investments in technology since.

Clear Street's Billion-Dollar IPO Ambitions are A Taste of What's to Come as Wall Street Prepares for a Year of Groundbreaking Debuts… 2026 is gearing up to be the year of the IPO boom, and Clear ...

Feb 4 (Reuters) - Drug developer Eikon ‍Therapeutics said on Wednesday it had raised $381.2 million in its U.S. initial public offering, selling about 21.2 million shares priced at $18 apiece. This ...